Skip to main content
. 2022 Dec 30;12(1):e027041. doi: 10.1161/JAHA.122.027041

Figure 2. Clinical characteristics of the patients with LVAA.

Figure 2

CMR indicates cardiovascular magnetic resonance; ERT, enzyme replacement therapy; HF, heart failure; ICD, implantable cardioverter‐defibrillator; LGE, late gadolinium enhancement; LVAA, left ventricular apical aneurysm; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; NA, not applicable; NYHA, New York Heart Association; and VT, ventricular tachycardia.